Expres2ion Biotech Hldg Stock Current Valuation
| 5JD Stock | EUR 1.77 0.06 3.28% |
Valuation analysis of EXPRES2ION BIOTECH HLDG helps investors to measure EXPRES2ION BIOTECH's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that EXPRES2ION BIOTECH's price fluctuation is abnormally volatile at this time. Calculation of the real value of EXPRES2ION BIOTECH HLDG is based on 3 months time horizon. Increasing EXPRES2ION BIOTECH's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the EXPRES2ION stock is determined by what a typical buyer is willing to pay for full or partial control of EXPRES2ION BIOTECH HLDG. Since EXPRES2ION BIOTECH is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EXPRES2ION Stock. However, EXPRES2ION BIOTECH's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.77 | Real 1.7 | Hype 1.77 | Naive 1.84 |
The real value of EXPRES2ION Stock, also known as its intrinsic value, is the underlying worth of EXPRES2ION BIOTECH HLDG Company, which is reflected in its stock price. It is based on EXPRES2ION BIOTECH's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of EXPRES2ION BIOTECH's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of EXPRES2ION BIOTECH HLDG helps investors to forecast how EXPRES2ION stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EXPRES2ION BIOTECH more accurately as focusing exclusively on EXPRES2ION BIOTECH's fundamentals will not take into account other important factors: EXPRES2ION BIOTECH HLDG Company Current Valuation Analysis
EXPRES2ION BIOTECH's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, EXPRES2ION BIOTECH HLDG has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current valuation for all Germany stocks is 100.0% higher than that of the company.
EXPRES2ION Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EXPRES2ION BIOTECH's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EXPRES2ION BIOTECH could also be used in its relative valuation, which is a method of valuing EXPRES2ION BIOTECH by comparing valuation metrics of similar companies.EXPRES2ION BIOTECH is currently under evaluation in current valuation category among its peers.
EXPRES2ION Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.34 | |||
| Shares Outstanding | 37.15 M | |||
| Shares Owned By Institutions | 1.71 % | |||
| Gross Profit | 6.22 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 12.79 X | |||
| Number Of Employees | 27 | |||
| Beta | 1.46 | |||
| Market Capitalization | 44 M |
About EXPRES2ION BIOTECH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EXPRES2ION BIOTECH HLDG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXPRES2ION BIOTECH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXPRES2ION BIOTECH HLDG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in EXPRES2ION Stock
EXPRES2ION BIOTECH financial ratios help investors to determine whether EXPRES2ION Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EXPRES2ION with respect to the benefits of owning EXPRES2ION BIOTECH security.